Give an overview.
A local subacute type III hypersensitivity reaction.
Typically caused by vaccination against tetanus and/or diphtheria.
Describe the pathophyisology.
Intradermal antigen injection in a presensitized individual (previously exposed to the antigen, with preformed, antigen-specific IgG in the serum) → formation of antigen-antibody complexes in the skin → complement activation → local inflammation and possibly necrosis
List clinical features.
Cutaneous small-vessel vasculitis [19]
Localized swelling, erythema, hemorrhage
Occasional superficial skin necrosis a few hours after booster vaccination
The reaction typically peaks after 12–36 hours.
DDs.
Injection site reaction unrelated to hypersensitivity
Abscess
Cellulitis
Shoulder injury related to vaccine administration
Describe diagnostics.
Increased tetanus and diphtheria antibody levels in the serum support the diagnosis.
Consider skin biopsy to rule out differential diagnoses.
Describe the treatment.
The reaction is self-limited.
Symptomatic relief of swelling (e.g., cold compresses, NSAIDs, limb elevation)
Evidence of vasculitis on histology differentiates between a true Arthus reaction and an injection site reaction unrelated to hypersensitivity.
Last changed2 years ago